Principal component analysis of FDG PET in amnestic MCI

PurposeThe purpose of the study is to evaluate the combined accuracy of episodic memory performance and 18F-FDG PET in identifying patients with amnestic mild cognitive impairment (aMCI) converting to Alzheimer’s disease (AD), aMCI non-converters, and controls.MethodsThirty-three patients with aMCI and 15 controls (CTR) were followed up for a mean of 21 months. Eleven patients developed AD (MCI/AD) and 22 remained with aMCI (MCI/MCI). 18F-FDG PET volumetric regions of interest underwent principal component analysis (PCA) that identified 12 principal components (PC), expressed by coarse component scores (CCS). Discriminant analysis was performed using the significant PCs and episodic memory scores.ResultsPCA highlighted relative hypometabolism in PC5, including bilateral posterior cingulate and left temporal pole, and in PC7, including the bilateral orbitofrontal cortex, both in MCI/MCI and MCI/AD vs CTR. PC5 itself plus PC12, including the left lateral frontal cortex (LFC: BAs 44, 45, 46, 47), were significantly different between MCI/AD and MCI/MCI. By a three-group discriminant analysis, CTR were more accurately identified by PET-CCS + delayed recall score (100%), MCI/MCI by PET-CCS + either immediate or delayed recall scores (91%), while MCI/AD was identified by PET-CCS alone (82%). PET increased by 25% the correct allocations achieved by memory scores, while memory scores increased by 15% the correct allocations achieved by PET.ConclusionCombining memory performance and 18F-FDG PET yielded a higher accuracy than each single tool in identifying CTR and MCI/MCI. The PC containing bilateral posterior cingulate and left temporal pole was the hallmark of MCI/MCI patients, while the PC including the left LFC was the hallmark of conversion to AD.

[1]  A Pupi,et al.  European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG. , 2002, European journal of nuclear medicine and molecular imaging.

[2]  Lippincott Williams Wilkins,et al.  THERMOREGULATION: RECENT CONCEPTS AND REMAINING QUESTIONS , 2008, Neurology.

[3]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[4]  R. Vandenberghe,et al.  Cognitive aging and Alzheimer’s disease , 2005, Postgraduate Medical Journal.

[5]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[6]  C. Caltagirone,et al.  The Mental Deterioration Battery: Normative Data, Diagnostic Reliability and Qualitative Analyses of Cognitive Impairment , 1996 .

[7]  Mony J. de Leon,et al.  Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints , 2008, Biological Psychiatry.

[8]  D. Loewenstein,et al.  Stability of Neurocognitive Impairment in Different Subtypes of Mild Cognitive Impairment , 2006, Dementia and Geriatric Cognitive Disorders.

[9]  L. Thurfjell,et al.  Implementation and validation of a fully automatic system for intra- and interindividual registration of PET brain scans. , 1997, Journal of computer assisted tomography.

[10]  Guido Rodriguez,et al.  Principal component analysis in mild and moderate Alzheimer's disease — A novel approach to clinical diagnosis , 2009, Psychiatry Research: Neuroimaging.

[11]  Charles DeCarli,et al.  Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment , 2003, The Lancet Neurology.

[12]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[13]  D. A. Bennett,et al.  Natural history of mild cognitive impairment in older persons , 2002, Neurology.

[14]  L Thurfjell,et al.  CBA--an atlas-based software tool used to facilitate the interpretation of neuroimaging data. , 1995, Computer methods and programs in biomedicine.

[15]  Aileen B. Sedman,et al.  A longitudinal study , 1987 .

[16]  B. Reisberg,et al.  Mild cognitive impairment , 2005, The Lancet.

[17]  E. Capitani,et al.  A normative study on visual reaction times and two Stroop colour-word tests , 1998, The Italian Journal of Neurological Sciences.

[18]  P Poulin,et al.  In vivo neuroanatomy of Alzheimer's disease: evidence from structural and functional brain imaging. , 2002, Brain and cognition.

[19]  D. Perani,et al.  MCI conversion to dementia and the APOE genotype , 2004, Neurology.

[20]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[21]  George Bartzokis,et al.  Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. , 2007, Brain : a journal of neurology.

[22]  P. Fossati,et al.  Verbal memory performance of patients with a first depressive episode and patients with unipolar and bipolar recurrent depression. , 2004, Journal of psychiatric research.

[23]  G Mariani,et al.  99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  D. Perani,et al.  Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. , 2005, Archives of neurology.

[25]  N. Lackey,et al.  Making Sense of Factor Analysis: The Use of Factor Analysis for Instrument Development in Health Care Research , 2003 .

[26]  L. Williams,et al.  Rates of decline distinguish Alzheimer's disease and mild cognitive impairment relative to normal aging: integrating cognition and brain function. , 2007, Journal of integrative neuroscience.

[27]  T. Greitz,et al.  A computerized brain atlas: construction, anatomical content, and some applications. , 1991, Journal of computer assisted tomography.

[28]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[29]  Cees Jonker,et al.  Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.

[30]  Henrik Zetterberg,et al.  Alzheimer's disease , 2006, The Lancet.

[31]  A. Convit,et al.  Reduced hippocampal metabolism in MCI and AD , 2005, Neurology.

[32]  Karl Herholz,et al.  On the multivariate nature of brain metabolic impairment in Alzheimer's disease , 2009, Neurobiology of Aging.

[33]  Christopher Clark,et al.  Disease-modifying therapies for Alzheimer disease , 2007, Neurology.

[34]  R. Cabeza,et al.  Imaging Cognition II: An Empirical Review of 275 PET and fMRI Studies , 2000, Journal of Cognitive Neuroscience.

[35]  H. Dringenberg,et al.  Alzheimer's disease: more than a ‘cholinergic disorder' — evidence that cholinergic–monoaminergic interactions contribute to EEG slowing and dementia , 2000, Behavioural Brain Research.

[36]  Clifford R Jack,et al.  Neuroimaging in Alzheimer disease: an evidence-based review. , 2003, Neuroimaging clinics of North America.

[37]  Uwe Haberkorn,et al.  Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease , 2007, Psychiatry Research: Neuroimaging.

[38]  L. Whalley,et al.  Brain ageing and dementia: what makes the difference? , 2002, The British journal of psychiatry : the journal of mental science.

[39]  N. Lackey,et al.  Making Sense of Factor Analysis , 2003 .

[40]  A. Drzezga,et al.  Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  M. Mesulam,et al.  Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum , 2004, Annals of neurology.

[42]  P. Hof,et al.  Hemispheric asymmetry, modular variability and age-related changes in the human entorhinal cortex , 2005, Neuroscience.

[43]  F. Pasquier,et al.  Memory Impairment Differs in Frontotemporal Dementia and Alzhemier’s Disease. , 2001, Neurocase.

[44]  J. Baron,et al.  FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment , 2005, Neurocase.

[45]  C. Loeb,et al.  Diagnostic evaluation of degenerative and vascular dementia. , 1983, Stroke.

[46]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[47]  Daniela Mapelli,et al.  Variability of Trail Making Test, Symbol Digit Test and Line Trait Test in normal people. A normative study taking into account age-dependent decline and sociobiological variables , 2002, Aging clinical and experimental research.

[48]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[49]  S. Katz,et al.  Progress in development of the index of ADL. , 1970, The Gerontologist.

[50]  R. Petersen,et al.  Antemortem diagnosis of frontotemporal lobar degeneration , 2005, Annals of neurology.

[51]  M. Bobinski,et al.  Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  A. Drzezga,et al.  Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[53]  Brigitte Landeau,et al.  Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study , 2005, NeuroImage.

[54]  H S Levin,et al.  Distinguishing normal and demented elderly with the selective reminding test. , 1989, Journal of clinical and experimental neuropsychology.

[55]  R. V. Van Heertum,et al.  Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia. , 2003, Seminars in nuclear medicine.

[56]  Elena Salvatore,et al.  Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson’s disease , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[57]  S. Birge,et al.  Clock Completion: An Objective Screening Test for Dementia , 1993, Journal of the American Geriatrics Society.

[58]  Henrik Zetterberg,et al.  Plasma Aβ in Alzheimer's disease—up or down? , 2006, The Lancet Neurology.

[59]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[60]  Claire O'Tuathail,et al.  Assessment of older people , 2006 .

[61]  H. Braak,et al.  Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis , 1996, Acta Neuropathologica.

[62]  G. Bartzokis,et al.  Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease , 2004, Neurobiology of Aging.

[63]  Alberto Pupi,et al.  18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease , 2007, Journal of Nuclear Medicine.

[64]  Yaakov Stern,et al.  Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance , 2004, NeuroImage.